Miransertib

SI-6457

Miransertib, >98% (HPLC)

CAS No. : [1313881-70-7]

Synonyms : ARQ-092

IUPAC Name : 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Miransertib selectively inhibits Akt1/2/3 with low‑nanomolar potency and strongly suppresses the AKT1‑E17K mutant. It is under investigation for PI3K/Akt‑driven tumors and Proteus syndrome and demonstrates additional efficacy against Leishmania, highlighting its versatility across oncology and infectious‑disease models.

References : Lapierre J. M. et al.: J. Med. Chem., 59(13), 6455-69, 2016; Devki Nandan et al.: PLoS One., 13(11), e0206920, 2018.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.